Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.

Administration of cyclosporin after syngeneic bone marrow transplantation paradoxically elicits a T lymphocyte-dependent autoaggression syndrome termed syngeneic graft-vs-host disease (SGVHD). The induction of SGVHD requires two essential components, the emergence of autoreactive lymphocytes from the thymus and the elimination of a T cell-dependent peripheral autoregulatory mechanism. These studies used the SGVHD model to further characterize this regulatory system that modifies the autoimmune potential of autoreactive effector cells. Our studies reveal that although cyclosporin did not interfere with the effector function of the autoregulatory T cells, it prevented the reconstitution of the regulatory system after syngeneic bone marrow transplantation. Furthermore, the autoregulation of SGVHD is a dynamic process specifically recognizing and responding to the autoreactive SGVHD effector cells. Challenge or priming of normal Lewis rats by intravenous infusion of irradiated SGVHD effector cells activates and amplifies this autoregulatory system resulting in: 1) a threefold enhancement of autoregulatory T cell function, 2) the appearance of a dominant autoregulatory T cell population belonging to the CD4+ T helper lymphocyte subset, and 3) the capacity of irradiated primed autoregulatory T cells to inactivate SGVHD effector lymphocytes in vitro. Additional studies reveal that effective autoregulation required a specific interaction of the TCR-alpha/beta on the autoregulatory cells with the MHC class II determinants on the autoreactive lymphocytes.

• Publication year

  1994

• Venue

  Journal of Immunology

• Publication date

  1994-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.153.1.400PMID 8207251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.

  1993cited by this paper
• Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential

  1993cited by this paper
• Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.

  1993cited by this paper
• SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE: VI. IN VITRO ALLOREACTIVITY OF T CELL SUBSETS FROM RATS WITH LONG‐SURVIVING ALLOGRAFTS1

  1993cited by this paper
• "Infectious" transplantation tolerance

  1993cited by this paper
• Biological properties of interleukin 10.

  1992cited by this paper
• Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated mice.

  1992cited by this paper
• Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.

  1992cited by this paper
• Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction

  1992cited by this paper
• PREVENTION OF SYNGENEIC GRAFT‐VERSUS‐HOST DISEASE BY RECOVERY OF THYMIC MICROENVIRONMENT AFTER CYCLOSPORINE

  1991cited by this paper
• Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease.

  1991cited by this paper
• THE THYMUS AND PROLONGED ADMINISTRATION OF CYCLOSPORINE: IRREVERSIBLE IMMUNOPATHOLOGIC CHANGES ASSOCIATED WITH AUTOLOGOUS PSEUDO‐GRAFT-VERSUS‐HOST DISEASE

  1990cited by this paper
• Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. III. Analysis of regulatory cells suppressing the induction of thyroiditis.

  1990cited by this paper
• Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes

  1990cited by this paper
• Idiotypic Regulation of T Cells in Graft‐Versus‐Host Disease and Autoimmunity

  1989cited by this paper
• Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease

  1989cited by this paper
• Cyclosporine.

  1989cited by this paper
• Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells

  1989cited by this paper
• Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease.

  1989cited by this paper
• Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes

  1989cited by this paper
• Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

  1989cited by this paper
• Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.

  1989cited by this paper
• Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.

  1989cited by this paper
• Abnormal differentiation of thymocytes in mice treated with cyclosporin A

  1988cited by this paper
• Effects of cyclosporine A on T cell development and clonal deletion.

  1988cited by this paper
• Cyclosporin A and the thymus. Immunopathology.

  1987cited by this paper
• T‐Cell Unresponsiveness in vivo and in vitro: Fine Specificity of Induction and Molecular Characterization of the Unresponsive State

  1987cited by this paper
• Immunogenicity and crossreactivity of specificity-associated markers on alloreactive T cells. Confirmation based on the model of tolerance abolition by adoptive transfer

  1986cited by this paper
• Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats

  1986cited by this paper
• Development of graft-vs.-host disease-like syndrome in cyclosporine- treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

  1985cited by this paper
• Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.

  1984cited by this paper
• Idiotypic receptors for soluble antigens on human T lymphocyte clones.

  1984cited by this paper
• Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

  1983cited by this paper
• Immunoregulatory T-cell pathways.

  1983cited by this paper
• A human suppressor T cell clone which recognizes an autologous helper T cell clone

  1982cited by this paper
• Sequential morphology of graft-versus-host disease in the rat radiation chimera

  1982cited by this paper
• Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture

  1982cited by this paper
• Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens

  1979cited by this paper
• Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells

  1978cited by this paper
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes

  1973cited by this paper

• Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.

  2014cites this paper
• response in the development of autologous GVHD disease (GVHD): evidence for the involvement of antigen-driven T-cell Characterization of the T-cell repertoire in autologous graft-versus-host

  2011cites this paper
• Human umbilical cord blood-derived stromal cells prevent graft-versus-host disease in mice following haplo-identical stem cell transplantation.

  2011cites this paper
• syndrome discrete from that observed with cyclosporin A disease mortality by rapamycin leads to a clinical-pathological In vivo inhibition of cytokine responsiveness and graft-versus-host

  2011cites this paper
• Reconstitution of self-tolerance after hematopoietic stem cell transplantation

  2010cites this paper
• Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

  2008cites this paper
• Modulation of graft-versus-host disease: role of regulatory T lymphocytes.

  2006cites this paper
• Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.

  2006cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2005cites this paper
• A Case of Systemic Sclerosis Developed after Autologous Hematopoietic Stem Cell Transplantation in the Patient with Multiple Sclerosis

  2005cites this paper
• CD11chigh Dendritic Cell Ablation Impairs Lymphopenia-Driven Proliferation of Naive and Memory CD8+ T Cells1

  2005cites this paper
• CD11c Dendritic Cell Ablation Impairs Lymphopenia-Driven Proliferation of Naive and Memory CD8 T Cells

  2005cites this paper
• Association of Foxp3 regulatory gene expression with graft-versus-host disease.

  2004cites this paper
• Second autologous transplant with cyclosporin/interferon α-induced graft versus host disease for patients who have failed first-line consolidation

  2004cites this paper
• CD4+ T Cells Prevent Skin Autoimmunity During Chronic Autologous Graft‐Versus‐Host‐Disease

  2004cites this paper
• Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.

  2004cites this paper
• Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cells

  2003cites this paper
• Cyclosporin A-Induced Autoimmunity in the Rat: Central versus Peripheral Tolerance

  2002cites this paper
• Autologous graft-versus-host disease in a porcine bone marrow transplant model

  2002cites this paper
• Susceptibility to cyclosporin A-induced autoimmunity: strain differences in relation to autoregulatory T cells.

  2002cites this paper
• Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.

  2001cites this paper
• Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.

  2000cites this paper
• Clinical course and predictive factors for cyclosporin‐induced autologous graft‐versus‐host disease after autologous haematopoietic stem cell transplantation

  2000cites this paper
• Immune tolerance to self-MHC class II antigens after bone marrow transplantation.

  1999cites this paper
• Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.

  1999cites this paper
• Cyclosporin A-induced autoimmunity: the result of defective de novo T-cell development.

  1998cites this paper
• Autologous graft-versus-host disease.

  1997cites this paper
• Immunobiology and immunotherapeutic implication of syneneic/autologous graft‐versus‐host disease

  1997cites this paper
• Role of the thymus in radiation-induced lung damage after bone marrow transplantation.

  1997cites this paper
• Separation of major histocompatibility complex (MHC) and non-MHC gene effects in the development of T cell subsets in relation to susceptibility to cyclosporine A-induced autoimmunity.

  1997cites this paper
• The treatment of relapsed or refractory intermediate grade non-Hodgkin’s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon

  1997cites this paper
• Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin) oxide and cyclosporine on thymus histophysiology.

  1997cites this paper
• Multiple effects of cyclosporin A on the thymus in relation to T-cell development and autoimmunity.

  1997cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Alterations of dendritic cells in the rat thymus without epithelial cell loss during cyclosporine treatment and recovery.

  1996cites this paper
• Susceptibility to clinically manifest cyclosporine A (CsA)‐induced autoimmune disease is associated with interferon‐gamma (IFN‐γ)‐producing CD45RC+RT6− T helper cells

  1996cites this paper
• The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells.

  1996cites this paper
• In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.

  1996cites this paper
• Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor response.

  1995cites this paper
• Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma.

  1995cites this paper
• Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.

  1995cites this paper
• Antitumor Activity of Syngeneic/Autologous Graft‐versus‐Host Disease a

  1995cites this paper
• X‐IRRADIATION OF THE THYMUS IS NOT REQUIRED FOR THE INDUCTION OF CYCLOSPORINE‐INDUCED AUTOIMMUNITY

  1995cites this paper
• Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.

  1995cites this paper
• Age, the thymus, and T lymphocytes.

  1995cites this paper
• Hauterkrankungen nach Organtransplantationen

  1995cites this paper